Overview of Consultation-Liaison Psychiatry: April 2017

3.00 CME
180 MINS
$30 FEE
SAVE
Psych Annals April 2017 Cover

Overview

Table of Contents

The Psychiatric Consultation-Liaison Service: Function and Follies

John Laurent, MD; Britta Ostermeyer, MD, MBA, FAPA; Charles H. Dukes, MD; and Ondria Gleason, MD

Delirium and Dementia: Bedside Assessment of Confusional States

John F. Linck, PhD, ABPP-CN; Christopher T. Copeland, PhD; Akshay Lokhande, MD, MHA; Irina Baranskaya, MD; Roopma Wadhwa, MD; Asim A. Shah, MD; and Britta Ostermeyer, MD, MBA, FAPA

Somatic Symptom and Related Disorders

Jessica Holster, PhD; Erin M. Hawks, PhD; and Britta Ostermeyer, MD, MBA, FAPA

Acute Management of Substance-Related and Addictive Disorders: A Review

Elizabeth Foote, MD; and Charles H. Dukes, MD

Chemotherapy, Immunotherapy, and Psychotropic Use in Cancer Patients: A Review of Psychiatric Side Effects

Natalie Kurkjian, MD; Phebe Tucker, MD; Britta Ostermeyer, MD, MBA, FAPA; and Alan Valentine, MD, FAPOS


Sponsorship Statement

This CME activity is jointly sponsored by Keck School of Medicine of USC and Psychiatric Annals.


Support Statement

There is no commercial support for this activity.


Learning Objectives

1. Describe the role and composition of the consultation-liaison psychiatry service.

2. Recognize the types of cognitive problems that will present in the hospital setting.

3. Identify the symptoms, etiology, assessment, and treatment of a somatic symptom and related disorders.

4. Recognize diagnosis and treatment recommendations for acute presentations of common intoxication and withdrawal syndromes presenting to the psychiatric consultation-liaison service.

5. Recognize psychiatric side effects and complications associated with chemotherapy and immunotherapy treatments.

Faculty names and affiliations:  See authors above

Guest Editor: Britta Ostermeyer, MD, MBA, FAPA

Reviewer names:  Jan Fawcett, MD, Editor, Psychiatric Annals; Andrew A. Nierenberg, MD, CME Coordinator, Psychiatric Annals


Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears at the beginning of each CME-accredited article in this issue and also on this page.

Faculty members report the following financial relationships:   Jan Fawcett, MD, has no relevant financial relationships to disclose. Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly and Company; EpiQ, Forest; Johnson and Johnson; Labopharm; Merck; Methylation Science; Novartis; PamLabs; PGx Health; Shire; Schering-Plough; Sunovion; Takeda/Lundbeck Pharmaceuticals; Targacept; Teva: Consultant. APSARD; Belvoir Publishing; Boston Center for the Arts; University of Texas Southwestern Dallas; Hillside Hospital; American Drug Utilization Review; American Society for Clinical Psychopharmacology; Bayamon Region Psychiatric Society; Baystate Medical Center; Canadian Psychiatric Association; Columbia University; Douglas Hospital/McGill University; IMEDEX; International Society for Bipolar Disorders; Israel Society for Biological Psychiatry; John Hopkins University; MJ Consulting; Massachusetts Association of College Counselors; Medscape; MBL Publishing; Physicians Postgraduate Press; Ryan Licht Sang Foundation; Slack Publishing; SUNY Buffalo; University of Florida; University of Miami; University of Wisconsin; University of Pisa; SciMed: Honoraria / travel expenses. Appliance Computing, Inc.; Brain Cells, Inc.: Stock options. AHRQ; Cephalon; Forest; Mylan; NIMH; PamLabs; Pfizer Pharmaceuticals; Takeda; Elan; Shire: Grant / research support.

Authors report the following financial relationships: Britta Ostermeyer has no relevant financial relationships to disclose. John Laurent has no relevant financial relationships to disclose. Charles H. Dukes has no relevant financial relationships to disclose. Ondria Gleason has no relevant financial relationships to disclose. John F. Linck has no relevant financial relationships to disclose. Christopher T. Copeland has no relevant financial relationships to disclose. Akshay Lokhande has no relevant financial relationships to disclose. Irina Baranskaya has no relevant financial relationships to disclose. Roopma Wadhwa has no relevant financial relationships to disclose. Asim A. Shah has no relevant financial relationships to disclose. Jessica Holster has no relevant financial relationships to disclose. Erin M. Hawks has no relevant financial relationships to disclose. Elizabeth Foote has no relevant financial relationships to disclose. Natalie Kurkjian has no relevant financial relationships to disclose. Phebe Tucker has no relevant financial relationships to disclose. Alan Valentine is a stock shareholder in Abbvie, Eli Lilly, Express Scripts, Johnson & Johnson, Merck, and Sanofi.

The staff of Keck School of Medicine of USC and Psychiatric Annals have disclosed no relevant financial relationships. Signed disclosures are on file at Keck School of Medicine of USC.


Accreditation statement(s)

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Keck School of Medicine of USC and SLACK Incorporated. The Keck School of Medicine of USC is accredited by the ACCME to provide continuing medical education for physicians.


Credit Designation

The Keck School of Medicine of USC designates this enduring material for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Release date:  April 1, 2017. Expiration Date:  May 1, 2020.


How to Participate

To participate in this CME activity, you must read the learning objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Keck School of Medicine of USC will issue an AMA PRA Category 1 Credit(s)™ certificate.


Target Audience

This CME activity is primarily targeted to patient-caring psychiatrists, physicians specializing in psychiatry and others allied to the field. There are no specific background requirements for participants taking this activity. Learning objectives and author disclosures are found at the beginning of each CME article.


Unlabeled and Investigational Usage Statement

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.


Copyright Statement

Copyright © 2017 by SLACK Incorporated. All rights reserved. No part of this publication may be reproduced without prior written consent of the publisher.